Today’s Solutions: February 13, 2025

Just over a year ago, we shared an article about how Moderna is using mRNA technology to develop an HIV vaccine. Last week, the Phase I clinical trials for this very vaccine began.

The company is conducting the trial in partnership with the nonprofit International AIDS Vaccine Initiative (IAVI) and hopes that the trial will confirm whether the vaccine can deliver HIV-specific antigens to the body to induce an immune response.

The 56 HIV-negative adult volunteers will be under the watchful eye of the researchers for six months. During the study, 48 of the participants will receive at least one dose of the primary vaccine, and 32 out of these 48 will also receive the booster. The remaining eight will receive only the booster vaccine.

“We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna’s mRNA platform,” said the president and CEO of IAVI Mark Feinberg in a statement. “The search for an HIV vaccine has been long and challenging and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine.”

Solutions News Source Print this article
More of Today's Solutions

America’s first car-free neighborhood is proving walkability works

BY THE OPTIMIST DAILY EDITORIAL TEAM In a country where the car is king, a bold car-free community in Arizona is challenging the status ...

Read More

Sniff, snuggle, snooze: Your lover’s scent may be the key to better sleep

BY THE OPTIMIST DAILY EDITORIAL TEAM Valentine’s Day is just around the corner! To celebrate this day of love, we’re bringing back this fascinating ...

Read More

4 simple ways to feel at your absolute best this summer

The sunshine of summer is enough to make you feel better than you usually do throughout the year. But with a few changes to ...

Read More

Here’s how to stop letting fear of failure hold you back

Failure in any of its forms, professional or personal, can discourage us from embarking on new endeavors. Here are five strategies to overcome the ...

Read More